Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Oral ivermectin versus malathion lotion for difficult-to-treat head Lice - (N Engl J Med)
    Diclofenac Gel Clears Actinic Keratoses Among Organ Transplant Recipients: Presented at AAD - (DGDispatch)
    Posaconazole Compares With Standard Onychomycosis Treatments: Presented at AAD - (DGDispatch)
    Minocycline Treatment Shows No Adverse Impact on Spermatogenesis: Presented at AAD - (DGDispatch)
    Ingenol Mebutate Gel 0.05% Decreases Actinic Keratosis Lesions: Presented at AAD - (DGDispatch)

    News archive

     Recent webcasts/CME - Dermatology Other
      Skin Cancer Update
      Tuberous Sclerosis
      Advances in the Treatment of Actinic Keratosis: Evidence-Based Approaches for Optimized Outcomes
      Adverse Cutaneous Reactions Induced by TNF-[alpha] Antagonist Therapy
      Advancements in Enzymatic Debridement: Applying Clinical Science to Everyday Applications

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Seborrheic Keratoses: A Distinctive Diagnoses Of Pigmented Vulvar Lesions: A Case Report
        A Family With Skin Lesions
        Thick Skin On The Back
        Allergic Reaction Related To Ramipril Use: A Case Report
        Sclerodermiform Porphyria Cutanea Tarda

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Multiple Myeloma Patients Treated With Thalidomide Can Experience Dermatologic Side Effects

        A DGReview of :"Dermatologic side effects of thalidomide in patients with multiple myeloma"
        Journal of the American Academy of Dermatology

        04/21/2003
        By David Ball


        Dermatologic side effects of thalidomide can be quite severe in some newly diagnosed patients with multiple myeloma, especially in conjunction with dexamethasone, say researchers in the United States.

        The prevalence of these side effects, which are minor in most patients, are higher than previously reported, they suggest.

        Further studies are needed "to verify the extent of the interaction between thalidomide and dexamethasone" in such patients, according to. V. C. Hall and clinicians at the Department of Dermatology, Mayo Clinic, Jacksonville, and the Department of Dermatology and Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

        While the teratogenic and neurologic side effects of thalidomide, approved by the FDA in 1998 for treating erythema nodosum leprosum, are well known, its dermatologic side effects are yet to be defined. Eighty seven patients with multiple myeloma were enrolled into this open-label clinical trial to examine these side effects.

        Records of all subjects were reviewed; 50 were treated with thalidomide alone and 57 with thalidomide and dexamethasone. Records were made of the frequency, severity, type and time of onset of all skin eruptions temporally related to the therapy.

        In subjects taking thalidomide alone, 46% were found to have minor to moderate skin eruptions compared with 43% of those taking thalidomide and dexamethasone. Included were seborrheic, morbilliform, maculopapular or nonspecific dermatitis.

        Three of those given thalidomide and dexamethasone developed severe skin reaction requiring hospitalisation and withdrawal of thalidomide. These reactions included exfoliative erythroderma, erythema multiforme and toxic epidermal necrolysis.
        J Am Acad Dermatol 2003 Apr;48(4):548-52. "Dermatologic side effects of thalidomide in patients with multiple myeloma"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send